HIV-1 evolution: Frustrating therapies, but disclosing molecular mechanisms

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 365, Issue 1548, 2010, Pages 1965-1973

  Das, Atze T ^a   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antiviral therapy; Drug resistance; Hiv 1 evolution; Molecular mechanism; Rna structure; Virus replication

Indexed keywords

DRUG RESISTANCE; GENOME; HUMAN IMMUNODEFICIENCY VIRUS; INHIBITOR; MOLECULAR ANALYSIS; MUTATION; RNA; VIRUS;

EID: 77954321324     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2010.0072     Document Type: Review

References (72)

1. Abbink, T. E. M. & Berkhout, B. 2003 A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the gag start codon. J. Biol. Chem. 278, 11601-11611. (doi:10.1074/jbc.M210291200)
2. Abbink, T. E. & Berkhout, B. 2007 RNA structure modulates splicing efficiency at the HIV-1 major splice donor. J. Virol. 82, 3090-3098. (doi:10.1128/JVI.01479-07)
3. Baba, T W., Jeong, Y. S., Penninck, D., Bronson, R., Greene, M. F. & Ruprecht, R. M. 1995 Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 267, 1820-1825. (doi:10.1126/science. 7892606)
4. Baba, T. W. et al. 1999 Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques. Nat. Med 5, 194-203. (doi:10.1038/8859)
5. Back, N. K. T., Nijhuis, M., Keulen, W., Boucher, C. A. B., Oude Essink, B. B., van Kuilenburg, A. B. P., Van Gennip, A. H. & Berkhout, B. 1996 Reduced replication of 3TC-resistant HIV-1 variants in primary cells due to a processivity defect of the reverse transcriptase enzyme. EMBO J. 15, 4040-4049.
6. Baldwin, C. E. & Berkhout, B. 2006 Second site escape of a T20-dependent HIV-1 variant by a single amino acid change in the CD4 binding region of the envelope glycoprotein. Retrovirology 3, 84. (doi:10.1186/1742- 4690-3-84)
7. Banerjea, A., Li, M. J., Bauer, G., Remling, L., Lee, N. S., Rossi, J. & Akkina, R. 2003 Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol. Ther. 8, 62-71. (doi: 10. 1016/S1525-0016(03) 00140-0)
8. Baron, U. & Bujard, H. 2000 Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances. Methods Enzymol. 327, 401-421. (doi:10.1016/S0076-6879(00)27292-3)
9. Berkhout, B. 2009 A new Houdini act: multiple routes for HIV-1 escape from RNAi-mediated inhibition. Future Microbiol. 4, 151-154. (doi:10.2217/17460913.4.2.151)
10. Berkhout, B. & de Ronde, A. 2004 APOBEC3G versus reverse transcriptase in the generation of HIV-1 drugresistance mutations. AIDS 18, 1861-1863. (doi: 10.1097/00002030-200409030-00022)
11. Berkhout, B. & Haasnoot, J. 2006 The interplay between virus infection and the cellular RNA interference machinery. FEBS Lett. 580, 2896-2902. (doi:10.1016/j.febslet.2006.02.070)
12. Berkhout, B. & Klaver, B. 1993 In vivo selection of randomly mutated retroviral genomes. Nucleic Adds Res. 21, 5020-5024. (doi:10.1093/nar/21.22. 5020)
13. Berkhout, B., Verhoef, K., van Wamel, J. L. & Back, N. K. 1999 Genetic instability of live, attenuated human immunodeficiency virus type 1 vaccine strains. J. Virol. 73, 1138-1145.
14. Berkhout, B., Das, A. T & Beerens, N. 2001 HIV-1 RNA editing, hypermutation and error-prone reverse transcription. Science 292, 7. (doi:10.1126/science.292.5514.7a)
15. Boden, D., Pusch, O., Lee, F., Tucker, L. & Ramratnam, B. 2003 Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 11, 11531-11535. (doi:10.1128/JVI.77.21.11531-11535.2003)
16. Breaker, R. R. 2004 Natural and engineered nucleic acids as tools to explore biology. Nature 432, 838-845. (doi: 10.1038/nature03195)
17. Chakrabarti, L. A., Metzner, K. J., Ivanovic, T., Cheng, H., Louis-Virelizier, J., Connor, R. I. & Cheng-Mayer, C. 2003 A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239-Deltanef increases viral replication. J. Virol. 11, 1245-1256. (doi:10.1128/JVI.77.2.1245-1256.2003)
18. Coffin, J. M. 1995 HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267, 483-489. (doi:10.1126/science.7824947)
19. Das, A. T., Klaver, B., Klasens, B. I. F., van Wamel, J. L. B. & Berkhout, B. 1997 A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 RNA genome is essential for replication. J. Virol. 71, 2346-2356.
20. Das, A. T., van Dam, A. P., Klaver, B. & Berkhout, B. 1998 Improved envelope function selected by long-term cultivation of a translation-impaired HIV-1 mutant. Virology 244, 552-562.
21. Das, A. T., Klaver, B. & Berkhout, B. 1999a A hairpin structure in the R region of the human immunodeficiency virus type 1 RNA genome is instrumental in polyadenylation site selection. J. Virol. 73, 81-91.
22. Das, A. T., Land, A., Braakman, I., Klaver, B. & Berkhout, B. 19996 HIV-1 evolves into a non-syncytium-inducing virus upon prolonged culture in vitro. Virology 263, 55-69. (doi:10.1006/viro.1999.9898)
23. Das, A. T., Brummelkamp, T. R., Westerhout, E. M., Vink, M., Madiredjo, M., Bernards, R. & Berkhout, B. 2004a Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78, 2601-2605. (doi:10.1128/JVI.78.5.2601-2605.2004)
24. Das, A. T., Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G. & Berkhout, B. 20046 Viral evolution as a tool to improve the tetracycline-regulated gene expression system. J. Biol. Chem. 279, 18776-18782. (doi:10.1074/jbc.M313895200)
25. Das, A. T., Harwig, A., Vrolijk, M. M. & Berkhout, B. 2007 The TAR hairpin of human immunodeficiency virus type-1 can be deleted when not required for Tat-mediated activation of transcription. J. Virol. 81, 7742-7748. (doi:10.1128/JVI.00392-07)
26. Domingo, E. & Wain-Hobson, S. 2009 The 30th anniversary of quasispecies. Meeting on 'Quasispecies: past, present and future'. EMBO Rep. 10, 444-448. (doi:10.1038/embor.2009.61)
27. Doria-Rose, N. A. & Vogt, V. M. 1998 In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal. J. Virol. 72, 8073-8082.
28. Gossen, M. & Bujard, H. 2001 Tetracyclines in the control of gene expression in eukaryotes. In Tetracyclines in biology, chemistry and medicine (eds M. Nelson, W. Hillen & R. A. Greenwald), pp. 139-157. Basel, Switzerland: Birkhäuser Verlag.
29. Haasnoot, J., Westerhout, E. M. & Berkhout, B. 2007 RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 25, 1435-1443. (doi:10.1038/nbt1369)
30. Hache, G., Shindo, K., Albin, J. S. & Harris, R. S. 2008 Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G. Curt. Biol. 18, 819-824. (doi:10.1016/j.cub.2008.04.073)
31. Hache, G., Abbink, T. E., Berkhout, B. & Harris, R. S. 2009 Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3G. J Virol. 83, 5956-5960. (doi: 10. 1128JVI.00045-09)
32. Hormann-Lehmann, R., Vlasak, J., Williams, A. L., Chenine, A. L., McClure, H. M., Anderson, D. C., O'Neil, S. & Ruprecht, R. M. 2003 Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. AIDS 17, 157-166. (doi:10.1097/00002030-200301240-00004)
33. Huthoff, H. & Berkhout, B. 2001 Two alternating structures for the HIV-1 leader RNA. RNA 1, 143-157. (doi:10.1017/S1355838201001881)
34. Johnson, R. P. & Desrosiers, R. C. 1998 Protective immunity induced by live attenuated simian immunodeficiency virus. Curr. Opin. Immunol. 10, 436-443. (doi:10.1016/S0952-7915(98)80118-0)
35. Keulen, W., Boucher, C. & Berkhout, B. 1996 Nucleotide substitution patterns can predict the requirements for drug-resistance of HIV-1 proteins. Antiviral Res. 31, 45-57. (doi:10.1016/0166-3542(96)00944-8)
36. Keulen, W., Back, N. K. T., van Wijk, A., Boucher, C. A. B. & Berkhout, B. 1997 Initial appearance of the 18411e variant in lamivudine-treated patients is caused by the mutational bias of the human immunodeficiency virus type 1 reverse transcriptase. J. Virol. 71, 3346-3350.
37. Klaver, B. & Berkhout, B. 1994 Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J 13, 2650-2659.
38. Klovins, J., Tsareva, N. A., de Smit, M. H., Berzins, V. & van Duin, J. 1997 Rapid evolution of translational control mechanisms in RNA genomes. J. Mol. Biol. 265, 372-384. (doi:10.1006/jmbi.1996.0745)
39. Koff, W. C. et al. 2006 HIV vaccine design: insights from live attenuated SIV vaccines. Nat. Immunol. 1, 19-23. (doi:10.1038/ni1296)
40. Lacey, S. F. & Larder, B. A. 1994 Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which are significant in nucleoside analog resistance. J. Virol. 5, 3421-3424.
41. Lee, S. K. et al. 2005 Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 106, 818-826. (doi:10.1182/blood-2004-10-3959)
42. Leonard, J. N., Shah, P. S., Burnett, J. C. & Schaffer, D. V. 2008 HIV evades RNA interference directed at TAR by an indirect compensatory mechanism. Cell Host Microbe 4, 484-494. (doi:10.1016/j.chom.2008.09.008)
43. Licis, N., Balklava, Z. & van Duin, J. 2000 Forced retroevolution of an RNA bacteriophage. Virology 271, 298-306. (doi:10.1006/viro.2000.0327)
44. Marzio, G., Verhoef, K., Vink, M. & Berkhout, B. 2001 In vitro evolution of a highly replicating, doxycyclinedependent HIV for applications in vaccine studies. Proc. Natl Acad. Sci. USA 98, 6342-6347. (doi: 10.1073/pnas.111031498)
45. Marzio, G., Vink, M., Verhoef, K., de Ronde, A. & Berkhout, B. 2002 Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription. J. Virol. 76, 3084-3088. (doi:10.1128/JVI.76.6.3084-3088.2002)
46. Mills, J., Desrosiers, R., Rud, E. & Almond, N. 2000 Live attenuated HIV vaccines: proposal for further research and development. AIDS Res. Hum. Retroviruses 16, 1453-1461. (doi:10.1089/088922200750005976)
47. Morris, S., Johnson, M., Stavnezer, E. & Leis, J. 2002 Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer. J. Virol. 76, 7571-7577. (doi:10.1128/JVI.76.15.7571-7577.2002)
48. Munoz, J. L., Parks, W P., Wolinsky, S. M., Korber, B. T. & Hutto, C. 1993 HIV-1 reverse transcriptase. A diversity generator and quasispecies regulator. Ann. NY Acad. Sci. 693, 65-70. (doi:10.1111/j.1749-6632.1993.tb26257. x)
49. Obbard, D. J., Gordon, K. H., Buck, A. H. & Jiggins, F. M. 2009 The evolution of RNAi as a defence against viruses and transposable elements. Phil. Trans. R. Soc. B 364, 99-115. (doi:10.1098/rstb.2008.0168)
50. Olsthoorn, R. C. L. & van Duin, J. 1996 Evolutionary reconstruction of a hairpin deleted from the genome of an RNA virus. Proc. Natl Acad. Sci. USA 93, 12 256-12 261. (doi:10.1073/pnas.93.22.12256)
51. Ooms, M., Huthoff, H., Russell, R., Liang, C. & Berkhout, B. 2004 A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions. J. Virol. 78, 10814-10819. (doi:10.1128/JVI.78.19.10814- 10819.2004)
52. Rieger, A. & Nassal, M. 1995 Distinct requirements for primary sequence in the 5′- and 3′-part of a bulge in the hepatitis B virus RNA encapsidation signal revealed by a combination in vivo selection/in vitro amplification system. Nucleic Acids Res. 23, 3909-3915. (doi:10.1093/nar/23.19. 3909)
53. Sun, X., Zhang, G. & Simon, A. E. 2005 Short internal sequences involved in replication and virion accumulation in a subviral RNA of turnip crinkle virus. J. Virol. 79, 512-524. (doi:10.1128/JVI.79.1.512-524.2005)
54. ter Brake, O., Konstantinova, P., Ceylan, M. & Berkhout, B. 2006 Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol. Ther. 14, 883-892. (doi:10.1016/j.ymthe.2006.07.007)
55. ter Brake, O., 't Hooft, K., Liu, Y. P., Centlivre, M., von Eije, K. J. & Berkhout, B. 2008a Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol. Ther. 16, 557-564. (doi:10.1038/sj.mt. 6300382)
56. ter Brake, O., von Eije, K. J. & Berkhout, B. 20086 Probing the sequence space available for HIV-1 evolution. AIDS 22, 1875-1877. (doi:10.1097/QAD.0b013e328309efe3)
57. Verhoef, K. & Berkhout, B. 1999 A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus. J. Virol. 73, 2781-2789.
58. Verhoef, K., Marzio, G., Hillen, W., Bujard, H. & Berkhout, B. 2001 Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat. J. Virol. 75, 979-987. (doi:10.1128/JVI.75.2.979-987.2001)
59. von Eije, K. J. & Berkhout, B. 2009 RNA-interference-based gene therapy approaches to HIV type-1 treatment: tackling the hurdles from bench to bedside. Antivir. Chem. Chemother. 19, 221-233.
60. von Eije, K. J., ter Brake, O. & Berkhout, B. 2008 Human immunodeficiency virus type 1 escape is restricted when conserved genome sequences are targeted by RNA interference. J. Virol. 82, 2895-2903. (doi:10.1128/JVI.02035-07)
61. von Eije, K. J., ter Brake, O. & Berkhout, B. 2009 Stringent testing identifies highly potent and escape-proof anti-HIV short hairpin RNAs. J. Gene Med. 11, 459-467. (doi:10.1002/jgm.1329)
62. Vrolijk, M. M., Ooms, M., Harwig, A., Das, A. T. & Berkhout, B. 2008 Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res. 36, 4352-4363. (doi:10.1093/nar/gkn364)
63. Vrolijk, M. M., Harwig, A., Berkhout, B. & Das, A. T. 2009 Destabilization of the TAR hairpin leads to extension of the polyA hairpin and inhibition of HIV-1 polyadenylation. Retrovirology 6, 13. (doi:10.1186/1742- 4690-6-13)
64. Westerhout, E. M., Ooms, M., Vink, M., Das, A. T. & Berkhout, B. 2005 HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33, 796-804. (doi: 10.1093/nar/gki220)
65. Whatmore, A. M., Cook, N., Hall, G. A., Sharpe, S., Rud, E. W & Cranage, M. P. 1995 Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence. J. Virol. 69, 5117-5123.
66. Whitney, J. B. & Ruprecht, R. M. 2004 Live attenuated HIV vaccines: pitfalls and prospects. Curr. Opin. Infect. Dis. 17, 17-26. (doi:10.1097/ 00001432-200402000-00004)
67. Yoon, M. & Spear, P. G. 2004 Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage. Proc. Natl Acad Sci. USA 101, 17 252-17 257. (doi: 10.1073/pnas.0407892101)
68. Zhang, J. & Simon, A. E. 2005 Importance of sequence and structural elements within a viral replication repressor. Virology 333, 301-315.
69. Zhou, X., Vink, M., Berkhout, B. & Das, A. T 2006a Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycyclinecontrol. Retrovirology 3, 82. (doi:10.1186/1742-4690-3-82)
70. Zhou, X., Vink, M., Klaver, B., Berkhout, B. & Das, A. T. 20066 Optimization of the Tet-On system for regulated gene expression through viral evolution. Gene Ther. 13, 1382-1390. (doi:10.1038/sj.gt.3302780)
71. Zhou, X., Vink, M., Klaver, B., Verhoef, K., Marzio, G., Das, A. T. & Berkhout, B. 2006c The genetic stability of a conditional-live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution. J Biol. Chem. 281, 17084-17091. (doi:10.1074/jbc.M513400200)
72. Zhou, X., Symons, J., Hoppes, R., Krueger, C., Berens, C., Hillen, W., Berkhout, B. & Das, A. T 2007 Improved single-chain transactivators of the Tet-On gene expression system. BMC Biotechnol. 7, 6. (doi:10.1186/1472-6750-7-6)